Akt2 Polyclonal Antibody

AKT2 is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT serine/threonine kinase 2 is a general protein kinase capable of phophorylating several known proteins.

The Akt2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Akt2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards Akt2.

The Akt2 Polyclonal Antibody exhibits exceptional sensitivity, enabling accurate quantification of Akt2 protein levels in both normal and disease states. It has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

With its superior performance and robustness, the Akt2 Polyclonal Antibody is an indispensable tool for researchers and scientists involved in studying Akt2 signaling pathways and its role in cellular processes such as cell growth, proliferation, and survival. Its versatility and reliability make it an ideal choice for a wide range of research applications.

The Akt2 Polyclonal Antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and saving valuable time in the laboratory. It is available in different sizes to accommodate various experimental needs.

Trust in the Akt2 Polyclonal Antibody to provide accurate and reproducible results, enabling groundbreaking discoveries in the field of Akt2 research.